Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)β’ Click on a phase to view related trials
A Study of CYP-001 in Combination with Corticosteroids in Adults with High-risk AGvHD
- Conditions
- Graft Versus Host Disease, Acute
- Interventions
- Drug: CorticosteroidsBiological: Placebo
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 60
- Registration Number
- NCT05643638
- Locations
- πΊπΈ
Banner MD Anderson, Phoenix, Arizona, United States
πΊπΈMayo Clinic Hospital, Jacksonville, Florida, United States
πΊπΈUniversity of Arkansas Medical Center, Little Rock, Arkansas, United States
Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers
- Conditions
- Cutaneous UlcerDiabetic Foot Ulcer
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 30
- Registration Number
- NCT05165628
- Locations
- π¦πΊ
Central Adelaide Local Health Network, Adelaide, South Australia, Australia
π¦πΊFiona Stanley Hospital, Perth, Western Australia, Australia
π¦πΊRoyal Perth Hospital, Perth, Western Australia, Australia
The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause
- Conditions
- Covid19Acute Respiratory Distress Syndrome
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 14
- Registration Number
- NCT04537351
- Locations
- π¦πΊ
Nepean Hospital, Kingswood, New South Wales, Australia
π¦πΊSt George Hospital, Kogarah, New South Wales, Australia
π¦πΊWestmead Hospital, Westmead, New South Wales, Australia
A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease
- Conditions
- Graft vs Host Disease
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 16
- Registration Number
- NCT02923375
- Locations
- π¦πΊ
Sydney Local Health District, Sydney, New South Wales, Australia
π¦πΊRoyal Adelaide Hospital, Adelaide, South Australia, Australia
π¬π§NHS Foundation Trust, Nottingham, United Kingdom